Clinical application of cerebrospinal fluid creatine phosphokinase determination.

The research article presents a study which measures the activity of creatine phosphokinase, a body enzyme, in the cerebrospinal fluid samples from 126 animals who were suspected to have diseases in the central nervous system. The study finds that high creatine phosphokinase values were observed in cases of certain diseases including feline toxoplasmosis, feline infectious peritonitis, seizure disorders and suspected poisonings, suggesting it could be used as a potential biomarker for these conditions.

Study Objective and Methodology

• The study set out to investigate the creatine phosphokinase activity in cerebrospinal fluid samples from animals who were suspected to suffer from central nervous system diseases. Creatine phosphokinase is an important enzyme indicative of muscle and brain tissue damage. When such health problems exist, this enzyme often finds its way into the cerebrospinal fluid.
• The researchers analyzed samples from 126 animals which had been submitted for analysis. They looked for creatine phosphokinase and measured its level in each sample.

Results and Observations

• In 32 of the samples, the creatine phosphokinase values obtained were less than 1 sigma unit/ml. In 94 samples, the values were less than or equal to 1 sigma unit/ml.
• The creatine phosphokinase values were found to be increased in all cases of feline toxoplasmosis and feline infectious peritonitis. This indicates that an increase in creatine phosphokinase activity could potentially signal the presence of these specific diseases in animals.
• An increase in creatine phosphokinase values was also noted in other cases, including seizure disorders and suspected poisonings. This suggests the possibility of its use as a biomarker in diagnosing such conditions.

Conclusions and Implications

• The researchers identified an apparent aid in prognosis for future cases. The increased creatine phosphokinase activity observed in several specific health issues suggests that it could be useful in predicting these conditions.
• While further investigations are necessary, this study contributes to the understanding of how creatine phosphokinase values can be utilized in diagnosing central nervous system diseases. The findings seem to indicate that this enzyme has the potential to serve as a reliable biomarker in veterinary medicine.